In the present study, by examining molecules that are differentially expressed in glioma stem cells and their non-stem cell counterparts, we revealed that MDM2, the major negative regulator of p53, was preferentially overexpressed in glioma stem cells. The gene discussed is TP53; the disease is central nervous system cancer.